Abbreviations & Acronyms AKI = acute kidney injury AKIN = Acute Kidney Injury Network CI = confidence interval eGFR = estimated glomerular filtration rate HR = hazard ratio OR = odds ratio PADUA = preoperative aspects and dimensions used for an anatomical PN = partial nephrectomy Objectives: To evaluate the incidence and predictors of acute kidney injury after clampless partial nephrectomy, and its impact on intermediate-term renal function. Methods: The incidence and severity of acute kidney injury were assessed for 262 patients undergoing clampless partial nephrectomy between 2010 and 2015. The association between perioperative covariates and acute kidney injury was evaluated using multivariate logistic regression analysis. An annual change in estimated glomerular filtration rate from 1 year after surgery was calculated according to the presence or absence of acute kidney injury. An impact of acute kidney injury on postoperative renal impairment, defined as a ≥25% estimated glomerular filtration rate decrease, was evaluated. Results: Overall, 21 (8.0%) patients experienced grade 1 acute kidney injury after clampless partial nephrectomy, and grade ≥2 acute kidney injury was not observed. High tumor complexity was the only independent predictor of acute kidney injury. Estimated glomerular filtration rate in patients with acute kidney injury improved within 1 year, and annual estimated glomerular filtration rate changes were similar among patients with or without acute kidney injury. Ultimately, 13 (5.0%) patients showed postoperative renal impairment during the median follow-up period of 37 months. Advanced age and diabetes mellitus were independent risk factors for renal impairment, but acute kidney injury was not. Conclusions: The incidence and severity of acute kidney injury after clampless partial nephrectomy are low. Low-grade acute kidney injury after clampless partial nephrectomy does not seem to affect intermediate-term renal function.
Introduction
Over the past few decades, PN has become the standard treatment for small renal masses 1 because of its equivalent oncological outcome and superior functional outcome compared with radical nephrectomy. 2, 3 Some patients, however, experience AKI after PN. AKI is defined as a sudden increase in serum creatinine, often accompanied by decreased urine output. AKI results from several causes, including sepsis, a cardiovascular event, nephrotoxic drugs, surgery and direct kidney injury. AKI increases morbidity and mortality, and predisposes patients to chronic kidney disease. 4 The incidence of AKI after PN with hilar clamping has been reported at 39-54% in several studies in which the duration and type of ischemia was associated with the incidence of AKI. [5] [6] [7] [8] [9] Some researchers showed that eGFR in a certain proportion of patients undergoing PN with hilar clamping remained significantly decreased during the relatively early postoperative period as a consequence of AKI. 5, 10 Recently, to prevent renal impairment, various clampless PN techniques, including robotic-assisted surgery, have been developed and utilized.
Unfortunately, the incidence of AKI after clampless PN and the impact of AKI after PN on the longitudinal change in postoperative renal function have not been well researched. In the present study, we investigated the incidence and predictors of AKI after clampless PN, and examined its impact on intermediate-term renal function.
Methods Patients
With institutional review board approval (approval number 1937, Tokyo Medical and Dental University), we reviewed 361 consecutive patients who had undergone gasless singleport PN in a single institution between 2010 and 2015. PN techniques utilized at our institution have been described previously. 12 In this surgery, PN is accomplished using an extraperitoneal approach through a single port without gas insufflation. Hilar clamping and renorrhaphy are not routinely used to avoid ischemic damage, additional nephron loss and possible occurrence of renal arterial pseudoaneurysm. 13 If necessary, renal hilar clamping and renorrhaphy can be carried out to control bleeding.
Of the 361 patients, six were converted to radical nephrectomy and were excluded from the analyses. Patients requiring hilar clamping (n = 21), and those with bilateral renal tumor (n = 26), metastatic renal cell carcinoma (n = 4), renal metastasis from other organs (n = 2), horseshoe kidney (n = 2), non-functioning contralateral kidney (n = 2), and an insufficient follow-up period (<1 year, n = 36) were also excluded. Finally, 262 patients were included in the present study. Clinicopathological and perioperative parameters were obtained from medical records by means of a retrospective review.
AKI after clampless PN
The incidence and severity of AKI after clampless PN was evaluated based on the AKIN classification.
14 AKI was defined as an abrupt reduction in kidney function with an increase in serum creatinine within 48 h after surgery. Although a decrease in urine output lasting >6 h was also included in the AKIN classification, the data on urine output were not fully recorded in our cohort. Therefore, a decrease in urine output was not taken into account for the evaluation of AKI in the present study, as previously reported. [5] [6] [7] The severity of AKI is categorized into three stages: (i) a 1.5-to 2.0-fold increase or a 0.3 mg/dL increase in serum creatinine from baseline for stage 1; (ii) a 2.0-to 3.0-fold increase for stage 2; and (iii) any increase >3.0-fold or >4.0 mg/dL in serum creatinine or the need for renal replacement therapy for stage 3.
The clinical covariates collected were sex, age, body mass index, comorbidities, preoperative eGFR (which was calculated using the Japanese Society of Nephrology equation 15 ), tumor size, PADUA score, 16 surgical duration, estimated blood loss and perioperative complications. The associations of the covariates with the incidence of AKI were investigated.
Intermediate-term change in renal function after clampless PN Serum creatinine was recorded annually after surgery for up to 5 years. The data obtained after tumor recurrence or metastasis were not used for analyses. Mean eGFR after clampless PN up to 5 years was plotted, and the annual change in eGFR from 1 year after surgery was calculated after stratifying the patients according to the presence or absence of AKI after clampless PN.
We defined postoperative renal impairment as a ≥25% ultimate eGFR decrease from preoperative eGFR, which was consistent with previous studies. 5, 17 The impact of AKI on renal impairment was evaluated. A temporary ≥25% eGFR decrease, which recovered thereafter, was not considered renal impairment.
Statistical analysis
The associations of the covariates with the incidence of AKI were investigated using a multivariate logistic regression analysis with backward stepwise elimination. The annual changes in eGFR were calculated using the linear mixed model. The advantage of the model is that this method is unaffected by dropout and can deal with an unequal number of serum creatinine measurements per patient. 18 The postoperative renal impairment-free survivals were evaluated by Kaplan-Meier analysis and compared using the log-rank test. The impact of AKI on renal impairment was analyzed using the Cox proportional hazards model with backward stepwise elimination. The linear mixed model was analyzed using R version 3.4.0 (2017; The R Foundation for Statistical Computing, Vienna, Austria), and the other analyses were carried out using JMP version 11.2.0 (SAS Institute, Cary, NC, USA). A P value <0.05 was considered significant.
Results
Patient and tumor characteristics, and surgical parameters are shown in Table 1 . In this cohort, 186 (71%) patients were men, and the median age was 58 years. Cardiovascular disease, hypertension, diabetes mellitus, dyslipidemia and hyperuricemia coexisted in 19 (7.3%), 97 (37%), 27 (10%), 40 (15%) and 36 (14%) patients, respectively. The median preoperative eGFR was 70.9 mL/min/1.73 m 2 , and 50 (19%) patients had an eGFR of <60 mL/min/1.73 m 2 . The median tumor size and PADUA score were 2.5 cm and 8, respectively, and there were 59 (23%) tumors with high tumor complexity (PADUA score ≥10). The median estimated blood loss and surgical duration were 314 mL and 214 min, respectively. The blood transfusion rate was 1.9%. No patients required conversion to open surgery. A total of 13 patients (5.0%) experienced Clavien-Dindo grade 3 complications, and none had Clavien-Dindo grade ≥4 complications. All 13 patients with grade 3 complications experienced urine leakage. Of these 13 patients, 12 were successfully treated with ureteral stent placement, and the remaining patient, who developed a perirenal infection, required open drainage in addition to ureteral stent placement.
During the median follow-up period of 37 months, no patients required temporary or permanent renal replacement therapy. Eight (3.4%) of 236 renal cell carcinoma patients experienced recurrence or metastasis. Although two patients (0.85%) died from other cancers, no patients died from renal cell carcinoma.
AKI after clampless PN
Overall, 21 (8.0%) patients experienced AKI after clampless PN. All AKI observed in the present study was stage 1, and no stage ≥2 AKI was observed. In univariate analysis, preoperative low eGFR (<60 mL/min/1.73 m 2 ), long surgical duration, increased estimated blood loss and high tumor complexity (PADUA score ≥10) were significantly associated with the onset of AKI. Multivariate analysis showed that high tumor complexity was the only independent predictor for AKI after clampless PN (OR 5.62, P < 0.001; Table 2 ).
Intermediate-term change in renal function after clampless PN
The mean ultimate eGFR change from preoperative baseline was À7.5% (range À67% to +27%) during the median follow-up period of 37 months. In patients without AKI, the eGFR change at 48 h after clampless PN was À4.1%, and the eGFR significantly declined with a slope of À0.39 mL/ min/1.73 m 2 /year (95% CI À0.74 to À0.04 mL/min/ 1.73 m 2 /year) from 1 year after surgery. In patients with AKI after clampless PN, eGFR improved up to À17% within 1 year after an initial change of À30% within 48 h, and the slope of eGFR from 1 year after surgery was À0.34 mL/min/1.73 m 2 /year (95% CI À1.23 to 0.54 mL/ min/1.73 m 2 /year; Fig. 1 ).
Renal impairment after clampless PN
Of the 262 patients, 13 (5.0%) had a ≥25% eGFR decrease at the most recent follow up. Three (14%) of 21 patients with AKI experienced renal impairment. Of these, the eGFR in two patients did not improve and remained ≥25% decreased during the follow-up period. In the remaining patient, eGFR had improved within 1 year and decreased thereafter. The 3-year 25% eGFR decrease-free survival rate was 90% in patients with AKI, and 97% in patients without AKI (P = 0.062; Fig. 2 ). Advanced age (≥65 years), diabetes mellitus and dyslipidemia were associated with a ≥25% eGFR decrease in univariate analysis, but AKI was not (P = 0.115). Multivariate analysis showed that advanced age (HR 6.84, P = 0.001) and diabetes mellitus (HR 5.03, P = 0.012) were the independent risk factors for renal impairment after clampless PN (Table 3) . When AKI was included into the multivariate model, it was not associated with the intermediateterm renal impairment. 
Discussion
The current study showed that the incidence and severity of AKI were low after clampless PN. In patients with AKI, renal function improved within 1 year after surgery, and the longitudinal change in renal function was similar to that in patients without AKI. As reported previously, the low-grade AKI observed in the present study did not increase the risk for intermediate-term renal impairment. 19 Patients undergoing surgery for a renal tumor are at high risk for AKI because of the nephron loss involved in the surgical procedures for renal tumors. Some studies have shown several factors associated with AKI after PN. 6, 8, 9, 20 Among them, renal ischemia is one of the most important. Although shorter ischemic time would have little impact on postoperative renal function, ischemic time could be extended according to tumor complexity and the surgeon's skill, which might actually increase the risk of AKI. Meanwhile, high tumor complexity was the only predictor for AKI after clampless PN. In cases with higher tumor complexity, AKI might be increased due to the greater nephron loss and the greater invasiveness during surgery. 21 Freedom from whole kidney ischemia or the consequent intimal injury by hilar clamping could explain why high-grade AKI was not observed in the current study. Recently, Dong et al. showed that devascularized parenchymal mass was associated with postoperative renal function. 22 Our surgical technique, in which renorrhaphy was not routinely carried out, might contribute to the preservation of renal function.
Although several investigators have suggested the association of AKI with short-term renal impairment after PN with hilar clamping, the present study showed that low-grade AKI after clampless PN was not associated with intermediate-term renal impairment. One possible explanation is that clampless PN avoids the renal ischemia and renorrhaphy that might result in irreversible nephron damage among a certain proportion of patients. Another possible explanation is that our gasless single-port technique contributes to reducing the surgical invasiveness, although there are some exceptional cases with greater estimated blood loss and longer surgical duration. The reduced invasiveness might be associated with the reversibility of the eGFR decrease. It is assumed that renal impairment can persist without significant recovery when high-grade AKI occurs, even after clampless PN, due to considerable nephron loss and the increased surgical invasiveness.
Longitudinal change in renal function from 1 year after clampless PN in patients with low-grade AKI that had recovered from the initial deterioration showed a similar tendency to that of patients without AKI. Imai et al. reported that the eGFR of the general Japanese population declined by 0.36 mL/min/1.73 m 2 each year. 23 Regardless of the occurrence of low-grade AKI, the longitudinal change in renal function of patients undergoing clampless PN might be identical to that of the general population, because advanced age and diabetes, which were shown to be the risk factors for intermediate-term renal impairment after clampless PN in the current study, were also risk factors for chronic kidney disease in the general population. 24 The present study was not without limitations. First, because of the nature of this retrospective study, urine output data were not fully obtained. In addition to an increase in serum creatinine within 48 h, a decrease in urine output lasting >6 h is also included in the AKIN definition. Therefore, the incidence and association with the longitudinal change in the renal function of AKI, including the decrease in urine output, should be clarified in future studies. Second, the present single center study had a small number of events and a relatively short-term follow-up period. Although the current results showing that high tumor complexity independently increased the risk of AKI and that AKI after clampless PN did not have a significant impact on intermediate-term renal function appear to be reasonable, larger studies with a longer follow-up period are required. Third, we used the Japanese Society of Nephrology equation for calculating eGFR and a ≥25% eGFR decrease as an index of renal impairment -these have not been established as the appropriate formula and index for patients undergoing clampless PN. Furthermore, the affected kidney function was not evaluated by renal scintigram, which might show the difference in dynamics of postoperative renal function between clamped or clampless PN. However, the relative change in eGFR for which the association with increasing risk of end-stage renal disease and mortality was shown in other studies was set as the end-point of the current study. 25, 26 Therefore, the results might not be affected by the formula used. Finally, we excluded patients without a healthy contralateral kidney from the analyses because of their small population. Interestingly, however, investigations of renal function after PN would be more important for these patients or for patients with preoperative renal impairment.
In conclusion, the incidence and severity of AKI after clampless PN were low, and low-grade AKI after clampless PN did not affect intermediate-term renal function. Clampless PN might contribute to the preservation of short-and intermediate-term renal function. 
